GEN1047 for Solid Tumors - First in Human (FIH) Trial

Clinical trial NCT05180474 · TERMINATED

Trial details

NCT number: NCT05180474
Sponsor: Genmab
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer, Breast Neoplasms Endometrial Cancer, Endometrial Neoplasm Ovarian Cancer, Ovarian Neoplasms Squamous Non Small Cell Lung Cancer (NSCLC-SCC)

Start date: 2021-12-13
Primary completion: 2026-03-25
Enrollment: 179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.